JPRN-jRCT2031210625招募中未知
Special Drug Use-results Survey of Targretin Capsules 75mg combined with photo(chemo)therapy for cutaneous T-cell lymphoma
pharmacovigilance departmant0 个研究点目标入组 70 人开始时间: 2022年2月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •(1) Cases in which UV therapy is being performed and the combined use of bexarotene and UV therapy is started during the registration period.
- •However, if bexarotene has been used, cases that have not been administered for more than 4 weeks since the last administration
- •(2) Cases registered for the first time in this survey
- •(3) Patients who have been treated with UV therapy at a standard frequency (at least once a week) for about one month before the start of concomitant use with bexarotene, and the status of the treatment can be confirmed.
- •(4) Cases in which the consent of the patient was obtained
排除标准
- •adult T-cell leukemia/lymphoma
研究者
相似试验
已完成
不适用
Special Drug Use Results Survey of Targretin capsules 75-mg in patients with Cutaneous T-cell LymphomasCutaneous T-Cell LymphomasJPRN-UMIN000022568Minophagen Pharmaceutical Co., Ltd.200
进行中（未招募）
不适用
Special drug-use survey of Tarlige tablet (evaluation of safety in long-term use)JPRN-jRCT2031200212Matsuoka Yomei900
招募中
不适用
Special drug-use survey of Tarlige (central neuropathic pain)Central neuropathic painJPRN-jRCT2031220132Matsuoka for Yomei400
已完成
Unknown
Special Drug Use-Results Survey of Onoacttachyarrhythmia, atrial fibrillation/atrial flutter in patients with cardiac dysfunctionJPRN-jRCT1080222572ONO PHARMACEUTICAL CO., LTD.800
已完成
Unknown
Special drug-use survey of Tarlige (evaluation of the efficacy in patients with peripheral neuropathic pain)JPRN-jRCT1080224913DAIICHI SANKYO CO., LTD1,890